August 2014 Analysis

Pages

Industry Trend Analysis - Swiss Biotech Companies Face Funding Challenges - AUG 2014

While capital investments in the Swiss biotech sector have not returned to pre-2007/08 financial downturn levels, the outperformance of the SXI Life Sciences Index is encouraging and highlights investor confidence in the sector. Switzerland's biotech industry is strategically important for the country's prosperity given the sector's high value-add.

READ FULL ARTICLE

Pages